© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Javier Cortés, MD | Authors
Articles
Javier Cortés, MD, on the CLEOPATRA Trial
October 15, 2015
In this interview we discuss the results of the CLEOPATRA trial, which studied the effect of adding pertuzumab to docetaxel and trastuzumab on HER2-positive metastatic breast cancer.